A Disease Overview
Systemic mastocytosis is a rare, clonal mast cell neoplasm driven by the KIT D816V mutation in ~95% of patients1-4. In patients with systemic mastocytosis, abnormal mast cell activation and uncontrolled mast cell proliferation result in unpredictable, debilitating symptoms1-4.
This module is intended to increase awareness of systemic mastocytosis among health care professionals to prevent delays in diagnosis. It includes information about diagnosis and pathogenesis of systemic mastocytosis and provides an overview of the patient experience and treatment options.
References: 1. Vaes M et al. Front Med. 2017;4:110. 2. Jara-Acevedo M et al. Mod Pathol. 2015;28(8):1138-1149. 3. Garcia-Montero AC et al. Blood. 2006;108(7):2366-2372. 4. Jennings SV et al. Immunol Allergy Clin North Am. 2018;38(3):505-525.